A new review of medical studies looks at the connection between the Epstein-Barr virus (EBV) and systemic lupus erythematosus (SLE), often called lupus. The review found that people with lupus are more likely to have been infected with EBV compared to healthy individuals. The virus also tends to be more active in lupus patients, with higher viral loads and more frequent reactivations.
The research shows that EBV-infected B cells in lupus patients have a unique genetic profile. This profile makes them better at presenting antigens and activating certain immune cells that can mistakenly attack the body's own tissues. This process may help explain how EBV could contribute to the development of lupus.
However, the exact ways EBV triggers lupus are still not fully clear. The review highlights that more research is needed to understand the precise mechanisms. Despite this, the findings point to new treatment ideas, such as therapies that target B cells to reduce EBV reservoirs or vaccines that prevent EBV infection.
These possible strategies are still being studied and are not yet standard treatments. The review emphasizes that while EBV appears to play a role, it is one of many factors in lupus. Patients should talk to their doctors about the latest research and treatment options.